These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 29702981
1. Clinical analysis of lectin-like oxidized low-density lipoprotein receptor-1 in patients with in-stent restenosis after percutaneous coronary intervention. Liu J, Liu Y, Jia K, Huo Z, Huo Q, Liu Z, Li Y, Han X, Wang R. Medicine (Baltimore); 2018 Apr; 97(17):e0366. PubMed ID: 29702981 [Abstract] [Full Text] [Related]
3. FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI. Song T, Fu Y, Wang Y, Li W, Zhao J, Wang X, Wang H, Zhao Y, Fu X. BMC Cardiovasc Disord; 2021 Jan 07; 21(1):24. PubMed ID: 33413149 [Abstract] [Full Text] [Related]
4. Intravascular Ultrasound and Angiographic Predictors of In-Stent Restenosis of Chronic Total Occlusion Lesions. Kang J, Cho YS, Kim SW, Park JJ, Yoon YE, Oh IY, Yoon CH, Suh JW, Youn TJ, Chae IH, Choi DJ. PLoS One; 2015 Jan 07; 10(10):e0140421. PubMed ID: 26465755 [Abstract] [Full Text] [Related]
5. Postprocedural serum sLOX-1 levels are associated with coronary in-stent restenosis in patients with stable coronary artery disease. Li B, Zhang LH, Yang XG, Liu Y, Liu XT, Ren YG. Coron Artery Dis; 2011 Jun 07; 22(4):259-63. PubMed ID: 21346562 [Abstract] [Full Text] [Related]
6. The value of serum visfatin in predicting in-stent restenosis of drug-eluting stents. Wu XA, Xie G, Li XQ, Wu HT, Wang X. Clin Chim Acta; 2018 Apr 07; 479():20-24. PubMed ID: 29305846 [Abstract] [Full Text] [Related]
7. A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents. Gai MT, Zhu B, Chen XC, Liu F, Xie X, Gao XM, Ma X, Fu ZY, Ma YT, Chen BD. Lipids Health Dis; 2021 Sep 29; 20(1):118. PubMed ID: 34587955 [Abstract] [Full Text] [Related]
8. Use of the neutrophil to lymphocyte ratio for prediction of in-stent restenosis in bifurcation lesions. Balli M, Taşolar H, Çetin M, Tekin K, Çağliyan ÇE, Türkmen S, Yilmaz M, Elbasan Z, Şahin DY, Çayli M. Eur Rev Med Pharmacol Sci; 2015 May 29; 19(10):1866-73. PubMed ID: 26044233 [Abstract] [Full Text] [Related]
9. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention. Xu HY, Qiao SB, Zhang JF, Dong QT, Li JJ. Coron Artery Dis; 2012 May 29; 23(3):181-7. PubMed ID: 22336660 [Abstract] [Full Text] [Related]
10. Analysis of the Correlation Between the Ratio of Monocytes to High-Density Lipoprotein Cholesterol and in-Stent Restenosis in Patients with Premature Coronary Heart Disease. Chen BW, Liu JJ, Xing JH, Liu HD, Wei YZ, Xue XF, Gu HP, Tao HL. Clin Appl Thromb Hemost; 2022 May 29; 28():10760296221079334. PubMed ID: 35187964 [Abstract] [Full Text] [Related]
11. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis. Gao J, Liu Y, Cui RZ, Mao YM, Zhou J, Chen Q, Zhao FM, Yang GM. Chin Med J (Engl); 2013 Mar 29; 126(6):1019-25. PubMed ID: 23506572 [Abstract] [Full Text] [Related]
12. Association of increased serum CTRP5 levels with in-stent restenosis after coronary drug-eluting stent implantation: CTRP5 promoting inflammation, migration and proliferation in vascular smooth muscle cells. Shen Y, Li C, Zhang RY, Zhang Q, Shen WF, Ding FH, Lu L. Int J Cardiol; 2017 Feb 01; 228():129-136. PubMed ID: 27863353 [Abstract] [Full Text] [Related]
13. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis. Tesche C, De Cecco CN, Vliegenthart R, Duguay TM, Stubenrauch AC, Rosenberg RD, Varga-Szemes A, Bayer RR, Yang J, Ebersberger U, Baquet M, Jochheim D, Hoffmann E, Steinberg DH, Chiaramida SA, Schoepf UJ. J Cardiovasc Comput Tomogr; 2016 Feb 01; 10(5):377-83. PubMed ID: 27431607 [Abstract] [Full Text] [Related]
15. Relationship between uric acid to albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting. Liu W, Ding K, Bao J, Hu Y, Gui Y, Ye L, Wang L. Coron Artery Dis; 2023 Dec 01; 34(8):589-594. PubMed ID: 37855441 [Abstract] [Full Text] [Related]
16. Resistant in-stent restenosis in the drug eluting stent era. Theodoropoulos K, Mennuni MG, Dangas GD, Meelu OA, Bansilal S, Baber U, Sartori S, Kovacic JC, Moreno PR, Sharma SK, Mehran R, Kini AS. Catheter Cardiovasc Interv; 2016 Nov 01; 88(5):777-785. PubMed ID: 27184223 [Abstract] [Full Text] [Related]
17. Red cell distribution width in coronary heart disease: prediction of restenosis and its relationship with inflammatory markers and lipids. Qian H, Luo Z, Xiao C, Chen J, Li D, Xu H, He P, Zhou X, Zhang T, Min X. Postgrad Med J; 2018 Sep 01; 94(1115):489-494. PubMed ID: 30301834 [Abstract] [Full Text] [Related]
18. Changes of plasma Rap1A levels in patients with in-stent restenosis after percutaneous coronary intervention and the underlying mechanisms. Gao H, Kuang Y, Liu Y, Zhang Y, Wang P, Ma Q. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Nov 28; 48(11):1650-1658. PubMed ID: 38432855 [Abstract] [Full Text] [Related]
20. [The predictive value of epicardial adipose tissue and inflammatory factors for in-stent restenosis]. Zhou QN, Lin WH, Jing R, Liu JJ, Shi HY, Yang RF, Gao P, Zhang Y. Zhonghua Yi Xue Za Zhi; 2019 Dec 17; 99(47):3732-3736. PubMed ID: 31874499 [Abstract] [Full Text] [Related] Page: [Next] [New Search]